falsefalse

The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac Involvement - Episode 1

AL Amyloidosis: Background, Patient Profile, and Staging

,

Expert oncologists Dr. Jeffrey Zonder and Dr. Shaji Kumar discuss AL amyloidosis background, typical patient profiles, and disease staging and risk stratification.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: AL Amyloidosis: Background, Patient Profile, and Staging
    EP. 2: Navigating the Differential Diagnosis of AL Amyloidosis
    EP. 3: Treatment Approaches in AL Amyloidosis
    EP. 4: Limitations of Available Treatment Options for Patients with Cardiac Involvement
    EP. 5: Birtamimab in AL Amyloidosis: Key Takeaways from the Phase III VITAL Trial
    EP. 6: Birtamimab Safety Profile in the VITAL Study
    EP. 7: Adverse Event Management in AL Amyloidosis
    EP. 8: Ongoing AFFIRM-AL Trial Background, Patient Eligibility, and Active Enrollment
    EP. 9: Revolutionizing the AL Amyloidosis Treatment Paradigm: Novel Agents and Combination Approaches
    EP. 10: Clinical Pearls and Future Directions in AL Amyloidosis

    Related Content:

    The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac InvolvementInsightsInsights Video Series
    The Future of CAR T-Cell Therapy in R/R DLBCL: Closing Reflections and Key Takeaways
    Key Takeaways: CAR T in Real-World Clinical Practice
    Overcoming Barriers and Improving CAR T Care in Academic and Community Settings
    x